Giuliana Cerro Chiang, MD, MSc
Assistant ProfessorCards
About
Research
Publications
2026
Idiopathic pulmonary fibrosis Epidemiology, natural history, and pathophysiology
Cerro-Chiang G, Al Jumaily K, Antin-Ozerkis D. Idiopathic pulmonary fibrosis Epidemiology, natural history, and pathophysiology. 2026, 111-132. DOI: 10.1201/9781003451259-7.Peer-Reviewed Original ResearchC40-01 Sarcoidosis and Connective Tissue Disease Overlap: Diagnostic and Therapeutic Challenges
De La Serna S, Cerro Chiang G. C40-01 Sarcoidosis and Connective Tissue Disease Overlap: Diagnostic and Therapeutic Challenges. American Journal Of Respiratory And Critical Care Medicine 2026, 212: aamag162.2687. DOI: 10.1093/ajrccm/aamag162.2687.Peer-Reviewed Original ResearchConnective tissue diseasePulmonary involvementCTD-ILDTissue diseaseHeterogeneous group of autoimmune disordersInflammatory cascadeLung diseaseMultidisciplinary discussionSystemic diseasePulmonary involvement of sarcoidosisSpectrum of pulmonary involvementType 1 T helper cellsAccurate diagnosisDisease of unclear etiologyGroup of autoimmune disordersMonitoring of treatment responseInvolvement of sarcoidosisHeterogeneous groupB-cell hyperplasiaCohort of patientsPresence of autoantibodiesInterstitial lung diseaseSystemic lupus erythematosusAdequate follow-upPatient-specific factorsAdvancing practitioner knowledge in interstitial lung disease: a review of free, online resources
Hwang J, Cerro Chiang G, Huie T, Kreider M, Zaman T. Advancing practitioner knowledge in interstitial lung disease: a review of free, online resources. ATS Scholar 2026, 7: 74-85. PMID: 41818781, PMCID: PMC13048464, DOI: 10.1093/atsscholar/aapaf006.Peer-Reviewed Original Research
2025
An exploratory analysis of differences in serum protein expression by sex in patients with systemic sclerosis associated interstitial lung disease
Cerro-Chiang G, Ayres M, Rivas A, Parker S, Mastali M, Chen P, Van Eyk J, Wolters P, Boin F, Zaman T. An exploratory analysis of differences in serum protein expression by sex in patients with systemic sclerosis associated interstitial lung disease. BMC Pulmonary Medicine 2025, 25: 16. PMID: 39806325, PMCID: PMC11727626, DOI: 10.1186/s12890-024-03474-z.Peer-Reviewed Original ResearchConceptsSSc-ILDInterstitial lung diseaseSerum protein expressionFVC declineProtein expressionLung diseaseMedian Follow-UpSpecimens of patientsBlood of patientsTime to event analysisPersonalized therapeutic strategiesConnective tissue diseaseLogistic regressionProportion of subjectsSex differencesChi-square testHigher mortality rateSSc patientsPulmonary vasculatureSystemic sclerosisBackgroundSystemic sclerosisResultsThe cohortTreatment responseTissue diseaseMultiple testing
2023
Protein biomarkers of disease progression in patients with systemic sclerosis associated interstitial lung disease
Cerro-Chiang G, Ayres M, Rivas A, Romero T, Parker S, Mastali M, Elashoff D, Chen P, Van Eyk J, Wolters P, Boin F, Zaman T. Protein biomarkers of disease progression in patients with systemic sclerosis associated interstitial lung disease. Scientific Reports 2023, 13: 8645. PMID: 37244972, PMCID: PMC10224939, DOI: 10.1038/s41598-023-35840-y.Peer-Reviewed Original ResearchConceptsInterstitial lung diseaseProgressive SSc-ILDSSc-ILDIngenuity Pathway AnalysisLung diseaseProgression of interstitial lung diseaseProgression of SSc-ILDDisease progressionAssociated with significant morbidityAssociated with disease progressionSSc-ILD cohortsBiomarkers of disease progressionConnective tissue diseaseRelevant to autoimmunityUnsupervised hierarchical clusteringProtein biomarkersForced Vital CapacityStable diseaseImmunosuppressant useRadiological featuresSignificant morbiditySystemic sclerosisUnsupervised cluster analysisBaseline characteristicsMultiple testingDifferences in Serum Protein Expression by Sex in Patients with Systemic Sclerosis Associated Interstitial Lung Disease
Chiang G, Boin F, Chen P, Zaman T. Differences in Serum Protein Expression by Sex in Patients with Systemic Sclerosis Associated Interstitial Lung Disease. American Journal Of Respiratory And Critical Care Medicine 2023, 207: a2575-a2575. DOI: 10.1164/ajrccm-conference.2023.207.1_meetingabstracts.a2575.Peer-Reviewed Original ResearchToxic Epidermal Necrolysis Presenting with Disseminated Intravascular Coagulopathy and Multiorgan Failure
Chiang G, Rojanapairat O. Toxic Epidermal Necrolysis Presenting with Disseminated Intravascular Coagulopathy and Multiorgan Failure. American Journal Of Respiratory And Critical Care Medicine 2023, 207: a5174-a5174. DOI: 10.1164/ajrccm-conference.2023.207.1_meetingabstracts.a5174.Peer-Reviewed Original ResearchBiomarker identification in fatal and post-acute sequelae of SARS-CoV-2 (PASC) lungs leads to epigenetic targeting in PASC-related fibrosis
Espindola M, Hohman M, Sá Y, Garcia S, Creyns B, Coelho A, Yao C, Chiang G, Parimon T, Strip B, Chen P, Hogaboam C. Biomarker identification in fatal and post-acute sequelae of SARS-CoV-2 (PASC) lungs leads to epigenetic targeting in PASC-related fibrosis. 2023, 201. DOI: 10.1183/23120541.lsc-2023.201.Peer-Reviewed Original ResearchUnderstanding Interstitial Lung Diseases Associated with Connective Tissue Disease (CTD-ILD): Genetics, Cellular Pathophysiology, and Biologic Drivers
Chiang G, Parimon T. Understanding Interstitial Lung Diseases Associated with Connective Tissue Disease (CTD-ILD): Genetics, Cellular Pathophysiology, and Biologic Drivers. International Journal Of Molecular Sciences 2023, 24: 2405. PMID: 36768729, PMCID: PMC9917355, DOI: 10.3390/ijms24032405.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsConceptsConnective tissue disease-associated interstitial lung diseaseInterstitial lung diseaseLung diseaseRisk factorsLung fibrosisSystemic autoimmune disorderConnective tissue diseaseFibrotic lung diseaseIdiopathic pulmonary fibrosisCommon risk factorsPre-clinical modelsLung fibroblast proliferationEnvironmental risk factorsPrimary pathogenic mechanismDisease biomarkersInflammatory cascadePulmonary fibrosisTissue diseaseAutoimmune disordersProfibrotic pathwaysDisease prognosticationPathogenetic mechanismsTargeted therapyCell dysfunctionEarly diagnosis
2022
Severe Nonspecific Interstitial Pneumonia (NSIP) in an Adolescent
Chiang G, Lee C, Marchevsky A, Lewis M. Severe Nonspecific Interstitial Pneumonia (NSIP) in an Adolescent. Case Reports In Pulmonology 2022, 2022: 7757776. PMID: 35982826, PMCID: PMC9381257, DOI: 10.1155/2022/7757776.Peer-Reviewed Original ResearchNonspecific interstitial pneumoniaInterstitial pneumoniaChildhood interstitial lung diseaseBilateral interstitial infiltratesCourse of steroidsHypoxemic respiratory failureInterstitial lung diseaseCritical care unitsYears of ageRespiratory failureAutoimmune serologyLaboratory workupCare unitInterstitial infiltratesLung diseasePneumoniaPartial recoveryChildrenInfiltratesBronchoscopyAdmissionSerologyWorkupYearsSteroids
Academic Achievements & Community Involvement
News
News
Get In Touch
Contacts
Locations
Lippard Laboratory of Clinical Investigation (LLCI)
Academic Office
15 York Street, Rm 101 E
New Haven, CT 06510